Millennium Management
WVE icon

Millennium Management’s Wave Life Sciences WVE Stock Holding History

Millennium Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.05M Buy
972,241
+387,608
+66% +$5.05M ﹤0.01% 2558
2025
Q4 		$9.94M Buy
584,633
+193,884
+50% +$1.97M ﹤0.01% 2274
2025
Q3 		$2.86M Sell
390,749
-301,666
-44% -$2.44M ﹤0.01% 3715
2025
Q2 		$4.5M Buy
692,415
+666,193
+2,541% +$4.4M ﹤0.01% 3100
2025
Q1 		$212K Sell
26,222
-1,154,616
-98% -$12.6M ﹤0.01% 5283
2024
Q4 		$14.6M Buy
1,180,838
+329,173
+39% +$4.39M 0.01% 1799
2024
Q3 		$6.98M Sell
851,665
-812,635
-49% -$4.86M ﹤0.01% 2532
2024
Q2 		$8.3M Buy
1,664,300
+28,690
+2% +$164K ﹤0.01% 2257
2024
Q1 		$10.1M Buy
1,635,610
+1,121,029
+218% +$5.61M ﹤0.01% 2184
2023
Q4 		$2.6M Buy
514,581
+259,687
+102% +$1.39M ﹤0.01% 3391
2023
Q3 		$1.47M Sell
254,894
-506,495
-67% -$2.31M ﹤0.01% 3865
2023
Q2 		$2.77M Sell
761,389
-667,102
-47% -$2.69M ﹤0.01% 3196
2023
Q1 		$6.18M Buy
1,428,491
+110,863
+8% +$508K ﹤0.01% 2416
2022
Q4 		$9.22M Buy
1,317,628
+760,071
+136% +$3.5M 0.01% 2219
2022
Q3 		$2.01M Sell
557,557
-517,476
-48% -$1.71M ﹤0.01% 3734
2022
Q2 		$3.49M Buy
1,075,033
+308,975
+40% +$594K ﹤0.01% 3154
2022
Q1 		$1.53M Sell
766,058
-326,040
-30% -$799K ﹤0.01% 4112
2021
Q4 		$3.43M Buy
1,092,098
+10,234
+0.9% +$42.5K ﹤0.01% 3263
2021
Q3 		$5.3M Sell
1,081,864
-55,666
-5% -$337K ﹤0.01% 2795
2021
Q2 		$7.58M Buy
1,137,530
+766,048
+206% +$5.01M ﹤0.01% 2240
2021
Q1 		$2.08M Buy
371,482
+255,344
+220% +$2.45M ﹤0.01% 3492
2020
Q4 		$914K Buy
116,138
+101,485
+693% +$852K ﹤0.01% 3793
2020
Q3 		$124 Sell
14,653
-108,734
-88% -$1.19M ﹤0.01% 4187
2020
Q2 		$1.28M Buy
+123,387
New +$1.16M ﹤0.01% 2844
2020
Q1 		– Sell
-39,335
Closed -$315K – 4572
2019
Q4 		$315K Buy
39,335
+27,873
+243% +$683K ﹤0.01% 3643
2019
Q3 		$235K Sell
11,462
-8,159
-42% -$187K ﹤0.01% 3709
2019
Q2 		$512K Sell
19,621
-55,217
-74% -$1.55M ﹤0.01% 3217
2019
Q1 		$2.91M Buy
74,838
+60,721
+430% +$2.46M ﹤0.01% 2149
2018
Q4 		$593K Sell
14,117
-72,232
-84% -$3.21M ﹤0.01% 2857
2018
Q3 		$4.32M Buy
+86,349
New +$3.9M 0.01% 1918
2018
Q2 		– Sell
-8,221
Closed -$330K – 4221
2018
Q1 		$330K Buy
+8,221
New +$346K ﹤0.01% 3180
2017
Q4 		– Sell
-44,241
Closed -$962K – 4118
2017
Q3 		$962K Sell
44,241
-27,948
-39% -$562K ﹤0.01% 2539
2017
Q2 		$1.34M Buy
+72,189
New +$1.56M ﹤0.01% 2306

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Millennium Management's WVE Position: Q1 2026 in Review

Millennium Management increased its Wave Life Sciences (WVE) stake by 66% in Q1 2026, buying an estimated $5.05M and bringing the position to 972,241 shares worth $7.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

Millennium Management first reported a position in WVE in Q2 2017 and has held it in 33 quarters since. The position peaked at $14.6M in Q4 2024. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Millennium Management held 972,241 shares of Wave Life Sciences worth $7.05M as of Q1 2026.
  • Millennium Management bought 387,608 Wave Life Sciences shares in Q1 2026, an estimated $5.05M.
  • Wave Life Sciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2558 holding.
  • Millennium Management first reported a position in Wave Life Sciences in Q2 2017 and has held it in 33 quarters since.
  • Millennium Management's Wave Life Sciences position peaked at $14.6M in Q4 2024.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.